With a push from the pandemic, digital health began to transform healthcare delivery. It has been particularly useful for advancing remote cardiac care. Massachusetts-based Infobionic, for example, has just launched a new continuous virtual telemetry platform — the first of its kind.

“As the industry has evolved through the COVID-19 pandemic, so has the need for greater reliance on remote monitoring, yet not just for cardiac arrythmias,” the company says. “The need to address the varying levels of clinical complexity from low acuity to high acuity with continuous cardiac telemetry in a remote or virtual care environment has risen to be one of the major efforts that healthcare is undertaking. The CMS hospital-without-walls and ensuing hospital-at-home initiatives have cemented their position towards this shift from brick-and-mortar care to virtual care.”

The MoMe™ ARC Platform is designed to ensure that all levels of acuity can be monitored in a virtual care environment and “hands power back to clinicians while enabling them to step confidently into virtual care.”

“When InfoBionic was founded more than a decade ago, we reimagined accepted norms for cardiac arrythmia detection with a full disclosure model that was built upon the principles of unwavering quality and continual innovation. Today, we're carrying those same pillars forward as we make yet another bold foray into the future of virtual healthcare,” says Stuart Long, CEO of digital health company InfoBionic.

Long notes that the pandemic and the need for remote monitoring is pushing the industry to “find ways to manage transferring patients from the hospital to the home on a platform that allows a seamless and unified monitoring experience, yet while being capable of extending and replicating as close to possible the step-down level of continuous telemetry monitoring they have in hospital.”

The future of remote cardiac telemetry, says Long, lies not just in the wearable device itself, but in the platform it serves. For example, the MoMe Kardia device, which currently can detect and diagnose up to 30 different arrythmias, records and sends the data in near-real time to the clinician, who then can take immediate action, should it be warranted.

Yet in virtual care, the goal for hospitals and health systems is to increase capacity and maximize resources to better manage patients by effectively removing the walls of the hospital.

“As a virtual telemetry company specialized in remote cardiac arrythmia monitoring, we are proud to deliver the MoMe ARC Platform,” says Long. “If the last few years have taught us one thing, it's that healthcare is changing. Care models are transforming. Providers are doing more in a virtual setting than ever before. Reimbursement paradigms are shifting to put value first. And clinicians are challenged to navigate all of this without ever losing focus on the patient. In order to support this new world of healthcare, telemetry must also adapt.”

Sherrie Trigg

Editor and Director of Medical Content